Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

View source ↗

Summary

The document reports the completion of a non-interventional study evaluating avelumab in patients with advanced or metastatic urothelial carcinoma and the posti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)

Snippet

Sponsor: Pfizer | Conditions: Urothelial Carcinoma | Status: COMPLETED | Results posted: 2026-04-02